The worldwide epidemic of obesity has increased the urgency to develop a deeper understanding of physiological systems related to energy balance and energy storage, including the mechanisms controlling the development of fat cells (adipocytes). The differentiation of committed preadipocytes to adipocytes is controlled by PPARc and several other transcription factors 1 , but the molecular basis for preadipocyte determination is not understood. Using a new method for the quantitative analysis of transcriptional components, we identified the zinc-finger protein Zfp423 as a factor enriched in preadipose versus non-preadipose fibroblasts. Ectopic expression of Zfp423 in non-adipogenic NIH 3T3 fibroblasts robustly activates expression of Pparg in undifferentiated cells and permits cells to undergo adipocyte differentiation under permissive conditions. Short hairpin RNA (shRNA)-mediated reduction of Zfp423 expression in 3T3-L1 cells blunts preadipocyte Pparg expression and diminishes the ability of these cells to differentiate. Furthermore, both brown and white adipocyte differentiation is markedly impaired in Zfp423-deficient mouse embryos. Zfp423 regulates Pparg expression, in part, through amplification of the BMP signalling pathway, an effect dependent on the SMAD-binding capacity of Zfp423. This study identifies Zfp423 as a transcriptional regulator of preadipocyte determination.
The worldwide epidemic of obesity has increased the urgency to develop a deeper understanding of physiological systems related to energy balance and energy storage, including the mechanisms controlling the development of fat cells (adipocytes). The differentiation of committed preadipocytes to adipocytes is controlled by PPARc and several other transcription factors 1 , but the molecular basis for preadipocyte determination is not understood. Using a new method for the quantitative analysis of transcriptional components, we identified the zinc-finger protein Zfp423 as a factor enriched in preadipose versus non-preadipose fibroblasts. Ectopic expression of Zfp423 in non-adipogenic NIH 3T3 fibroblasts robustly activates expression of Pparg in undifferentiated cells and permits cells to undergo adipocyte differentiation under permissive conditions. Short hairpin RNA (shRNA)-mediated reduction of Zfp423 expression in 3T3-L1 cells blunts preadipocyte Pparg expression and diminishes the ability of these cells to differentiate. Furthermore, both brown and white adipocyte differentiation is markedly impaired in Zfp423-deficient mouse embryos. Zfp423 regulates Pparg expression, in part, through amplification of the BMP signalling pathway, an effect dependent on the SMAD-binding capacity of Zfp423. This study identifies Zfp423 as a transcriptional regulator of preadipocyte determination.
There has been great progress in unravelling the transcriptional pathways controlling adipocyte differentiation-the process by which committed preadipose fibroblasts undergo a morphological and biochemical transition into mature adipocytes in response to appropriate cues 1 . However, little is known about how the determined preadipose state is controlled, particularly the transcriptional mechanisms that distinguish preadipocytes from non-adipogenic fibroblasts. There have been considerable barriers to the discovery of genes that control preadipocyte determination. First, preadipose commitment seems to be a quantitative trait, thus genes controlling this cellular state may be controlled quantitatively rather than qualitatively 2 . Second, although molecular markers to allow for the enrichment of a preadipocyte population from adipose tissue now exist 3, 4 , markers specific for the purification of preadipose fibroblasts and non-adipogenic fibroblasts from adipose tissue are lacking. Furthermore, immortalized preadipose cell lines have disparate histories and are notoriously aneuploid, potentially confounding the appropriate designation of cells as nonpreadipose or preadipose 5, 6 .
To identify the molecular mechanisms controlling preadipocyte commitment, we used the strategy summarized in Supplementary  Fig. 1 . We first derived 42 new clonal sublines of Swiss 3T3 fibroblasts, and evaluated their adipogenic potential. Oil-Red-O staining of accumulated lipids after the induction of differentiation showed six highly adipogenic preadipose cell lines, as well as six cell lines with little adipogenic potential (,10% of cells) ( Fig. 1a, b ). Next, we devised a real-time PCR platform to quantitatively determine the expression of all or nearly all transcription regulators (,1,800) encoded by the mouse genome. This new transcription-factor primer array, which we refer to as 'Quanttrx', is based on previous work on the derivation of in situ hybridization probes targeting the messenger RNAs encoding murine transcriptional components 7 . We improved this methodology by building a high-throughput platform for quantitative real-time PCR, using newly designed real-time PCR primers that amplify a more comprehensive set of all known or predicted murine transcriptional components (see Methods and Supplementary Fig. 1 ).
We performed Quanttrx assays on proliferating adipogenic and non-adipogenic fibroblasts in culture, before the growth arrest period that precedes the induction of adipose differentiation (Supplementary Fig. 1 ). This was to ensure that these data would not include genes in which expression was primarily linked to the differentiation process per se. We identified five genes in which expression was enriched in non-adipogenic fibroblasts, and four genes in which expression was enriched in preadipose fibroblasts ( Supplementary Fig. 2 and Supplementary Data Set 1). One of the genes enriched in preadipocytes was Pparg, a dominant and essential regulator of both brown and white adipocyte differentiation [8] [9] [10] ( Supplementary Fig. 2b ). Analysis of Pparg expression levels in these cell lines with isoform-specific primers indicated that Pparg2 mRNA levels, but not Pparg1 levels, were more abundant in preadipose fibroblasts than in non-adipogenic fibroblasts ( Supplementary Fig. 3 ). However, the expression of wellcharacterized differentiation-dependent regulators of Pparg expression did not correlate with the adipogenic potential of these cell lines ( Supplementary Fig. 4 ). As anticipated and discussed earlier, the correlation between these genes and the adipogenic potential of the fibroblasts was not perfect. For most of these genes, the adipogenic clone Swiss 27 resembled that of a non-adipogenic fibroblast, whereas the gene expression pattern of the non-adipogenic clone Swiss 30 more closely resembled the pattern found in preadipose cells ( Supplementary Fig. 2a, b ). We focused on components enriched in most preadipocytes, which might serve as initiators of preadipocyte commitment. Ectopic expression of PLZF (also known as Zbtb16) or Foxa2 in non-adipogenic fibroblasts did not render cells competent to undergo adipogenesis (data not shown). On the contrary, gain-of-function experiments described later led us to study extensively the large C2H2 zinc-finger protein Zfp423, which was initially isolated from a yeast two-hybrid screen for interacting partners of the EBF family of transcription factors in the olfactory epithelium 11 . With the exception of the two consistently outlying clones (Swiss 27 and Swiss 30), levels of Zfp423 mRNA were higher in all preadipose cell lines when compared to the non-adipogenic fibroblasts ( Fig. 1c ). 3T3-L1 preadipocytes show the greatest adipogenic potential in the response to the standard hormonal cocktail, and have by far the highest mRNA and protein levels of Zfp423 ( Fig. 1c, d ). Conversely, we did not detect either Zfp423 mRNA or protein in NIH 3T3 fibroblasts-cells with the least potential for adipogenesis under our experimental conditions ( Fig. 1c, d) . In most preadipocyte cell lines examined, the expression of Zfp423 is not significantly regulated during their differentiation into fat cells; therefore, the expression of Zfp423 is not necessarily linked to the differentiation step of adipogenesis ( Supplementary Fig. 5 ). In mice, Zfp423 mRNA levels were enriched in white and brown adipose tissue, as well as in the brain where Zfp423 has numerous functions ( Supplementary Fig. 6 ). Analysis of fractionated adipose tissue indicates that Zfp423 mRNA is abundantly expressed in both the stromal-vascular fraction of the tissues that contain committed preadipocytes, and in the mature adipocytes ( Supplementary Fig. 7 ). On the contrary, we did not detect appreciable Zfp423 mRNA expression in primary myoblasts, or C2C12 myoblasts (data not shown), suggesting that Zfp423 was not a general regulator of precursor specification in mesenchymal lineages.
To evaluate the role of Zfp423 in preadipocyte commitment, we first ectopically expressed Zfp423 in non-adipogenic NIH 3T3 fibroblasts; these cells do not express detectable Zfp423 and have very little potential for adipogenesis. Retroviral expression of Zfp423 resulted in a 12-fold increase in Pparg2 mRNA levels in the undifferentiated state ( Fig. 2a ), whereas the expression of Pparg1 remained undetectable ( Supplementary Fig. 3 ). The 12-fold increase in Pparg2 expression brought the total Pparg2 mRNA levels to the same levels observed in most preadipocyte cell lines ( Supplementary Fig. 3 ). On the other hand, the expression of most known upstream regulators of Pparg2 was not significantly altered ( Fig. 2a ). In response to pro-differentiative cell culture conditions, Zfp423-expressing cells underwent robust adipocyte differentiation, giving rise to lipid accumulating cells that express molecular markers of differentiated adipocytes (Fig. 2b, c) . These data indicate that Zfp423 can regulate Pparg gene expression in undifferentiated fibroblasts and can render these cells competent to undergo adipocyte differentiation.
We investigated the requirement of Zfp423 in preadipocytes by using specific shRNA sequences targeting Zfp423. Retroviral delivery of Zfp423 shRNA into 3T3-L1 preadipocytes greatly reduced the expression of Zfp423 in undifferentiated cells ( Fig. 2d, e ). Likewise, both Pparg1 and Pparg2 expression were significantly lower in Zfp423 knockdown preadipocytes when compared to control cells ( Fig. 2d, e ). In contrast, known upstream activators of Pparg transcription were either unaltered or even upregulated in Zfp423-deficient preadipocytes ( Fig. 2e ). In response to pro-differentiative cell culture conditions, Zfp423-deficient 3T3-L1 cells failed to undergo significant adipocyte differentiation, as indicated by the presence of fewer lipid accumulating cells ( Fig. 2f ) and lower expression of adipocyte-selective genes ( Fig. 2g ). As Zfp423 is also abundantly expressed in the stromalvascular fraction of brown adipose tissue (BAT) ( Supplementary  Fig. 7 ), we knocked down Zfp423 expression in immortalized BAT precursor cells and found that Pparg1 and Pparg2 expression in these cells was also Zfp423-dependent ( Supplementary Fig. 8 ). In addition, Prdm16, a BAT-selective regulator of PPARc expression and activity 12, 13 , was modestly but significantly decreased in Zfp423-deficient brown preadipocytes ( Supplementary Fig. 8 ).
As a complementary approach, we evaluated the ability of primary mouse embryonic fibroblasts (MEFs) from Zfp423-deficient mice to undergo adipogenesis 14 . Cultures of wild-type primary MEFs contained undetectable basal levels of Pparg mRNA (data not shown); therefore, the effect of Zfp423 deficiency on basal Pparg gene expression could not be explored in this model. However, differentiated cultures of primary MEFs isolated from embryonic day (E) 13.5 Zfp423-knockout embryos had significantly fewer lipid-laden adipocytes when compared to differentiated cultures from wild-type controls ( Supplementary Fig. 9a ). Expression of adipocyte genes in these cultures was also reduced ( Supplementary Fig. 9b ). Furthermore, the adipocytes that did arise in the cultures of Zfp423-knockout MEFs appeared smaller than those found in wild-type cultures, with less overall lipid accumulation ( Supplementary Fig. 9a ). The defect in adipogenesis probably lies upstream or at the level of Pparg activation, because ectopic expression of PPARc in Zfp423-knockout MEFs stimulates adipogenesis (data not shown). Taken together, these results clearly indicate that Zfp423 functions as a critical regulator of Pparg expression in the preadipocyte state, and is required for normal morphological and molecular differentiation of adipocytes.
Next, we evaluated the requirement of Zfp423 in the regulation of the broader preadipocyte gene expression program, particularly genes related to the committed state. To determine an expression signature that defines a committed 3T3 preadipocyte, we performed global expression profiling of several adipogenic and non-adipogenic cell lines using gene arrays. Unsupervised sample clustering indicated that all four adipogenic clones examined had a closer gene expression pattern to one another than to non-adipogenic cells ( Supplementary  Fig. 10 ). From the expression data we derived a gene expression signature consisting of 48 genes that characterizes the determined preadipose state (see Methods and Supplementary Table 1 ). To determine whether Zfp423 regulates the molecular identity of committed preadipocytes, we analysed the expression of all 48 genes plus the other transcriptional components identified by the Quanttrx assays in 3T3-L1 preadipocytes expressing control or the Zfp423 shRNA. Of the eight transcriptional components assayed in Zfp423deficient preadipocytes, three genes (Pparg2, Pou3f3 and Hmx1) were significantly altered in a direction consistent with a non-adipogenic fibroblast phenotype ( Supplementary Fig. 11a ). In addition, although their observed differences were not statistically significant, Jazf1 and Satb1 also seemed to be upregulated in Zfp423-shRNA-expressing preadipocytes ( Supplementary Fig. 11a ). This suggests the presence of a Zfp423-dependent transcriptional hierarchy in preadipose fibroblasts. Notably, of the 32 genes that normally have enriched expression in non-adipogenic fibroblasts, 19 were Zfp423-dependent (Supplementary Fig. 11b ). Of the 13 genes enriched in preadipocytes, the expression of 10 was Zfp423-dependent, with 7 showing lower preadipocyte gene expression in the absence of Zfp423 ( Supplementary  Fig. 11c ). Taken together, these data demonstrate that a main portion of the preadipose gene expression program is dependent on Zfp423.
Numerous studies have implicated the BMP and SMAD signalling cascade in the early events of adipogenesis, particularly in the induction of PPARc [15] [16] [17] [18] [19] . Interestingly, Zfp423 was previously identified as a BMP-dependent transcriptional coactivator of SMAD proteins 20 . Thus, we first asked whether the SMAD-interaction domain of Zfp423 is required for its pro-adipogenic actions under the standard adipocyte differentiation conditions. In addition, we asked whether Zfp423, by means of the SMAD-interaction domain, mediates the pro-adipogenic response to BMPs. We compared cells expressing full-length Zfp423 to cells expressing a mutant of Zfp423 that lacks the well-characterized SMAD-binding domain (termed Zfp423 (DSBD)) 20 (Fig. 3a) . When stable NIH 3T3 cell lines expressing either full-length Zfp423 or Zfp423(DSBD) were studied (Fig. 3b ), we observed that basal Pparg2 expression in undifferentiated fibroblasts was similarly induced by both proteins (Fig. 3c ). Furthermore, both the full-length protein and Zfp423 mutant were equally capable of inducing adipogenesis, as shown by the comparable expression of adipocyte-selective mRNAs in differentiated cultures and similar morphological appearance of lipid-accumulating fat cells (Fig. 3d) . Thus, the SMAD-binding domain of Zfp423 is not required for the adipogenic activity of Zfp423 under these typical cell culture conditions.
We also treated proliferating control or Zfp423-expressing cells with BMP4 and measured Pparg2 mRNA levels before the induction of differentiation (Fig. 3e ). Relatively high concentrations of BMP4 (.25 ng ml 21 ) were required to induce Pparg2 expression in control fibroblasts (Fig. 3e ). In sharp contrast, NIH 3T3 cells ectopically expressing wild-type Zfp423 showed a significant leftward shift of the BMP dose-response curve, with Zfp423-expressing cells being much more sensitive to low BMP4 concentrations (.100-fold induction at 12 ng ml 21 ) (Fig. 3e ). To determine whether the SMADinteraction domain of Zfp423 is required for this effect of the BMP proteins, we compared Pparg mRNA levels in BMP-treated control, Zfp423-expressing and Zfp423(DSBD)-expressing cell lines. Indeed, Zfp423-mutant-expressing cells failed to respond to the BMP signal to enhance Pparg gene expression further (Fig. 3f ). In addition, although cells expressing full-length Zfp423 were capable of undergoing BMP-driven adipogenesis, cells expressing Zfp423(DSBD) or the empty viral vector did not undergo significant adipocyte differentiation when stimulated with low doses of BMP4 (Fig. 3g) . Similar results were observed when we treated these same cell lines with BMP2 ( Supplementary Fig. 12 ). These results indicate that the SMAD-binding domain of Zfp423 is not necessary for its activity in preadipocyte commitment under basal culture conditions, but it is absolutely required for Zfp423 modulation of adipogenic activity induced by BMPs.
To determine whether Zfp423 regulates adipose cell development in vivo, we examined the formation of adipocytes in Zfp423-deficient mice 14 . Zfp423-knockout mice show large defects in the development of the midline structures of the brain 14, 21 , and most of these Zfp423 2/2 mice died within 24 h of birth 14, 21, 22 . Although the few recovered postnatal Zfp423 2/2 mice showed noticeable defects in adipose mass (data not shown), we could not exclude the possibility that alterations in energy balance, secondary to central nervous system abnormalities, lead to reduced energy storage in adipose tissues. Thus, we focused our analysis here on E18.5 of mouse development, where Zfp423 2/2 embryos are found in normal Mendelian ratio and are grossly indistinguishable from littermate controls.
Transverse sections of the thoracic region of E18.5 mice showed abundant interscapular BAT in all Zfp423 1/1 mice examined (Fig. 4a) . In contrast, the interscapular BAT in all Zfp423 2/2 embryos examined was much smaller and appeared grossly abnormal when compared to the BAT found in wild-type mice (Fig. 4b, c ). Furthermore, remnant BAT from mutant mice contained large amounts of interspersed connective tissue when compared to controls ( Fig. 4d, e ). FABP4 antibody staining indicated that although the remaining BAT in Zfp423-knockout mice expressed FABP4 ( Supplementary Fig. 13a-c) , UCP1 expression was nearly absent in most of the remnant BAT of knockout embryos, suggesting poor differentiation of the remaining adipose cells ( Supplementary Fig.  13d-h) . Within the mesodermal lineages, these histological abnormalities seemed specific to the adipose tissue, as muscle and connective tissues surrounding the BAT in the Zfp423 2/2 embryos appeared grossly normal (data not shown).
White fat cells first appear in the latest stages of embryogenesis, with the full expansion of white adipose tissue occurring postnatally, when the need for energy storage increases. We localized developing white adipocytes by FABP4 antibody staining of the subcutaneous regions in E18.5 embryos. We easily identified numerous FABP4 1 , lipid-laden cells in Zfp423 1/1 mice at this stage. These adipocytes were indeed white adipocytes, as UCP1 1 cells were not observed anywhere in the embryonic subcutaneous regions examined (data not shown). However, in the subcutaneous layer of littermate Zfp423 2/2 mice there was a great reduction in lipid-containing FABP4 1 cells (Fig. 4f, g) . On average, we identified 121 6 6 (mean 6 s.e.m.) lipid-containing FABP4 1 cells per mm 2 of subcutaneous tissue in E18.5 Zfp423 1/1 mice (,5 cells per 340 field). Zfp423 2/2 mice showed only an average of 32 6 7 of lipid-containing FABP4 1 cells per mm 2 of equivalent sections (,1 cell per 340 field) ( Fig. 4h) . These data reveal a genetic requirement for Zfp423 in the initial formation of both brown and white adipocytes in vivo.
Taken together, these data identify Zfp423 as a regulator of preadipose cell determination, and suggest a model in which the regulation of the preadipocyte levels of Pparg by Zfp423 (and probably other, unknown regulators) represents a crucial determinant of preadipocyte commitment ( Supplementary Fig. 14) . The differentiation signals, such as the standard hormonal cocktail used in our in vitro differentiation assays, function in large part to stimulate the expression and activity of PPARc in preadipocytes further until a critical threshold to initiate adipocyte differentiation is achieved. Although sensitizing cells to the BMP signals represents one mechanism by which Zfp423 regulates Pparg expression, future experiments must delineate the other mechanisms by which Zfp423 controls Pparg expression, as well as the regulatory pathways acting upstream of, and parallel to, Zfp423 in preadipocyte determination.
METHODS SUMMARY
For adipocyte differentiation assays, confluent cultures of 3T3-L1 and Swiss 3T3 subclones were exposed to induction medium containing dexamethasone (1 mM), insulin (5 mg ml 21 ), isobutylmethylxanthine (DMI; 0.5 mM) and 10% FBS. Forty-eight hours after induction, cells were maintained in DMEM containing insulin (5 mg ml 21 ) and 10% FBS until they were ready for collection. For NIH 3T3 cells, differentiation medium contained DMI, 6% FBS and 1 mM rosiglitazone. After induction, cells were maintained in medium containing 6% FBS, insulin and 1 mM rosiglitazone until they were ready for collection. For BMPinduced adipogenesis of NIH 3T3 cell lines, cells were grown to confluence, and maintained at post-confluence, in medium containing 6 ng ml 21 BMP4 or 25 ng ml 21 BMP2 along with insulin and rosiglitazone. The derivation and genotyping of Zfp423-knockout mice has been previously described 14, 23 . All animal experiments were performed according to procedures approved by the Dana-Farber Cancer Institute's and Beth Israel Deaconess Medical Center's Institutional Animal Care and Use Committee.
METHODS
Derivation of Swiss 3T3 subclones and 3T3 cell culture. Swiss 3T3, 3T3-L1 and NIH 3T3 cells (American Type Culture Collection) were cultured in DMEM (Invitrogen) with 10% bovine serum (Invitrogen) at 10% CO 2 . For adipocyte differentiation assays, 3T3-L1 and Swiss 3T3 subclones were grown to confluence in medium containing 10% bovine serum. At confluence, cells were exposed to induction medium containing dexamethasone (1 mM), insulin (5 mg ml 21 ), DMI (0.5 mM) and 10% FBS. Forty-eight hours after induction, cells were maintained in DMEM containing insulin (5 mg ml 21 ) and 10% FBS until they were ready for collection. For differentiation of NIH 3T3 cells, cells were grown to confluence in DMEM containing 10% bovine serum then induced in medium containing DMI, 6% FBS and 1 mM rosiglitazone. After induction, cells were maintained in medium containing 6% FBS, insulin (5 mg ml 21 ), and 1 mM rosiglitazone until they were ready for collection. For BMP-induced adipogenesis of NIH 3T3 cell lines, cells were grown to confluence, and maintained at post-confluence, in medium containing 6 ng ml 21 BMP4 (R&D Systems) or 25 ng ml 21 BMP2 (Peprotech), along with insulin and rosiglitazone.
Limiting dilution of cells into 96-well plates was used to derive subclones of parental Swiss 3T3 fibroblasts. 0.2 cells per well were seeded in a total of five 96-well plates. After 10-14 days, 45 wells containing cells at approximately 70% confluence were trypsinized and further propagated in 48-well, then 12-well, and finally 6-well dishes. Forty-two cell lines were initially screened for adipogenic potential after induction with DMEM containing DMI. The six most adipogenic and the six least adipogenic clones were selected for further analysis. Cells with abnormal fibroblast morphology were discarded. Oil-red-O staining. After 5-8 days of differentiation, cells were washed once in PBS and fixed with freshly prepared 4% formaldehyde, 13 PBS for 15 min. Oilred-O staining solution was performed as previously described 24 . RNA isolation and real-time PCR analysis. Total RNA from cultured cells or mouse tissues was isolated by Trizol extraction and purification using QIAGEN RNeasy mini columns according to the manufacturer's instructions. For realtime PCR analysis, 1-2 mg total RNA was reverse transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). SYBR green reactions using the SYBR Green PCR Master Mix (Applied Biosystems) were assembled along with 250 nM primers according to the manufacturer's instructions and performed using an ABI 7900 HT machine. Relative expression of mRNA was determined after normalization to Rps18 levels using the DD2C t method. Student's t-test was used to evaluate statistical significance. All primer sequences are available on request. Quantitative analysis of transcriptional components. First we have modified the list of transcriptional components described in ref. 7 by: (1) removing most extraneous genes that were obviously not directly involved in transcriptional regulation (for example, protein kinases, cytoplasmic nucleotide-binding proteins), (2) adding all known or predicted transcriptional co-activators, co-repressors, and histone-modifying enzymes, and (3) adding various housekeeping genes for data normalization ( Supplementary Table 2 ). Second, we have redesigned and synthesized new primers for these genes, suitable for use in real-time PCR analysis (Supplementary Data Set 2). These primers were designed so that they can be used at a common annealing temperature and produce single amplicons small enough for efficient amplification. Importantly, more than 95% of the primers efficiently amplified single PCR amplicons when tested in real-time PCR, with melting curve analysis using cDNA from various adult mouse tissues (data not shown). Last, we used robotic liquid handlers for automated assembly of SYBR green PCR reactions in 384-well reaction plates, enabling rapid and accurate high-throughput gene expression measurements. Primers amplifying transcriptional components were synthesized by Integrated DNA Technologies. Validated real-time PCR primer sequences were either obtained from Primer Bank (http://pga.mgh.harvard. edu/primerbank/) or designed using the Primer 3 program (http://frodo.wi.mit. edu/primer3/). All primers were designed or selected to amplify products 50-200 base pairs in size at an annealing temperature of 60 uC. All primer sequences are available in Supplementary Data Set 2.
Forward and reverse primers were first combined and distributed into five 384-well storage plates at a concentration of 100 mM. CyBi-Well Vario 384 robotics were then used to dilute and distribute primers at a final concentration of 250 nM into 384-well qPCR reaction plates (Applied Biosystems). SYBR green reactions were assembled by combining cDNA synthesized from 10 mg total RNA (as described earlier) with SYBR green master mix and distributing to five 384-well plates containing pre-aliquoted primers.
For gene expression analysis of adipogenic and non-adipogenic fibroblasts, RNA was extracted from sub-confluent cells grown in non-differentiating conditions. To identify the nine transcriptional components shown in Supplementary Fig. 2 , we selected genes in which the expression level in all adipogenic cell lines assayed was at least twofold different than the levels found in any of the non-adipogenic cell lines (P , 0.05 from Student's t-test), with the exception of the consistently outlying Swiss 27 and Swiss 30 clones. We also required that the differences in gene expression be reproducible (P , 0.05 from Student's t-test), when individual quantitative PCR assays were repeated with newly extracted RNA from triplicate cultures. Western blot analysis. Whole-cell extracts were prepared from cells by homogenization in lysis buffer containing 50 mM Tris, pH 8.0, 180 mM NaCl, 1% Triton X-100, 0.2% sarkosyl, 10% glycerol and 1 mM EDTA, supplemented with protease inhibitor cocktail (Sigma) and phenylmethylsulphonyl fluoride (PMSF). Fifty micrograms of whole-cell lysate was separated by SDS-PAGE and transferred to an immobilon P membrane (Millipore). For Zfp423 immunoblots, membranes were blocked in 10% milk, 0.1% Tween in PBS for $1 h, and then incubated overnight at 4 uC with anti-Zfp423 monoclonal antibody (BD Biosciences) diluted 1:1,000 in 10% milk, 0.1% Tween in PBS. For preadipocyte PPARc detection, PPARc was immunoprecipitated from 1 mg whole-cell lysate (Santa Cruz E-8 antibody) and then detected by western blot with a PPARc antibody (Santa Cruz H-100 antibody). Proteins were visualized using the Supersignal West Dura HRP Detection Kit (Pierce). Viral vectors and retrovirus production. Full-length coding sequence of murine Zfp423 (NCBI accession NM_033327) was PCR-amplified from mouse white adipose tissue cDNA and cloned into the XhoI/AgeI sites of pMSCV-puro retroviral vector (Clontech) in frame with an amino-terminal Flag tag. The SMAD-binding mutant of Zfp423 lacking zinc fingers 14-20 was generated by PCR and cloned into the pMSCV vector. Double-stranded DNA sequence encoding the shRNA targeting Zfp423 was selected from the Broad Institute public database (https://www. broadinstitute.org/genome_bio/trc/publicGetTransFromGeneNameForm.html?) and cloned into the AgeI/EcoRI sites of the pMKO-1 U6 retroviral vector. The pMKO-1 vector expressing shRNA targeting GFP was used as a negative control. The selected DNA sequence encoding the Zfp423 shRNA used in this study is as follows: forward oligonucleotide, 59-CCGGCCCTGAATGTAACGTGAAGTTC TCGAGAACTTCACGTTACATTCAGGGTTTTTG-39; reverse oligonucleotide, 59-AATTCAAAAACCCTGAATGTAACGTGAAGTTCTCGAGAACTTCACGTT ACATTCAGGG-39. Retroviral production and transduction of target cells were performed as previously described 24 .
Transcriptional profiling and derivation of the preadipocyte gene signature. Total RNA was isolated from indicated cell lines in triplicate and used for microarray analysis. Array hybridization and scanning were performed by the Dana-Farber Cancer Institute Core Facility using Affymetrix GeneChip Mouse Genome 430 2.0 arrays according to established methods 25 . The array data were normalized using the DNA-Chip Analyser (dChip) software 26 To derive a preadipocyte gene expression signature we first selected genes in which expression in the group of adipogenic cell lines was on average $2-fold different from the average expression value found among the non-adipogenic clones. The statistical significance of these differences in gene expression was assessed by an unpaired t-test (P , 0.05). From this list of 151 genes we manually selected the genes in which expression in all of the individual adipogenic cell lines examined was $2-fold different than the expression levels found in any of the individual non-adipogenic cell lines. The resulting gene set, consisting of 48 genes, is shown in Supplementary Table 2 . Complete microarray data are available at Gene Expression Omnibus 27 (http:// www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc5GSE19732). Animals and genotype analysis. The derivation of Zfp423-knockout mice has been previously described 14, 23 . All animal experiments were performed according to procedures approved by the Dana-Farber Cancer Institute's and Beth Israel Deaconess Medical Center's Institutional Animal Care and Use Committee. Mice were maintained on a standard rodent chow diet with 12 h light and dark cycles. Zfp423 mice were maintained on a C57/Bl6 background. Genotyping was performed by PCR as previously described 14, 23 . For timed matings, the first appearance of vaginal plugs was designated as E0.5. Preparation of primary MEFs and induction of adipocyte differentiation. Primary MEF were isolated from embryos of wild-type and Zfp423-null mice at E13.5 days. Embryos were removed and separated from maternal tissues and yolk sacs, then decapitated, finely minced, digested with 0.25% trypsin, 1 mM EDTA for 30 min at 37 uC, and centrifuged for 5 min at 2,000g. The pellet was resuspended in culture medium before plating. Cells were cultured at 37 uC in DMEM supplemented with 10% heat-inactivated FBS. All differentiation experiments were carried out using cells at passage 2. Adipocyte differentiation was induced as described earlier for 3T3-L1 cells with the exception that 1 mM rosiglitazone was added to the induction and maintenance medium. Immunohistochemistry. For histological analysis of embryonic adipose tissue, thoracic regions of decapitated embryos were fixed in 4% formaldehyde or Bouin's fixative for 24 h, embedded in paraffin and cut to 6-mm sections on slides. Immunohistochemistry was performed using the Vectastain Elite ABC Kit according to the manufacturer's instructions using rabbit FABP4 antiserum (1:2,000) (gift from D. Bernlohr) or rabbit UCP1 antibodies (1:500).
